Wilson Sonsini Goodrich & Rosati advised Cognito on the transaction. Neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Inscopix on the deal. Bruker Corporation, a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SR One on the deal. Simcha Therapeutics, a biotechnology company developing cytokine-based cancer immunotherapies, announced the closing of a $40...
You must be a Standard 1 Year member to access this content.
